Prostate Cell News Volume 14.10 | Mar 17 2023

    0
    21







    2023-03-17 | PCN 14.10


    Prostate Cell News by STEMCELL Technologies
    Vol. 14.10 – 17 March, 2023
    TOP STORY

    A Hotspot for Posttranslational Modifications on the Androgen Receptor Dimer Interface Drives Pathology and Anti-Androgen Resistance

    Scientists thoroughly studied the effects of selected mutations that span the complete dimer interface of the androgen receptor ligand–binding domain using x-ray crystallography in combination with in vitro, in silico, and cell-based assays.
    [Science Advances]

    Full ArticlePress Release
    Register for a recorded organoid panel discussion moderated by Dr. James Wells
    PUBLICATIONSRanked by the impact factor of the journal

    Inhibition of CDKL3 Downregulates STAT1 Thus Suppressing Prostate Cancer Development

    Researchers showed that CDKL3 was significantly upregulated in prostate cancer tissues compared with adjacent normal tissues, and was significantly positively correlated with tumor malignancy.
    [Cell Death & Disease]

    Full Article

    TRIM28 Promotes Luminal Cell Plasticity in a Mouse Model of Prostate Cancer

    Scientists studied the role of tripartite motif-containing 28 (TRIM28) in prostate cancer progression in vivo and generated a genetically-engineered mouse model, combining prostate-specific inactivation of Trp53, Pten, and Trim28.
    [Oncogene]

    AbstractGraphical Abstract

    ARF3 Weights the Balance for Prostate Cancer Metastasis

    Investigators determined the contribution of the ARFome to the morphology and migration of prostate cancer cells within 3D culture.
    [Journal Of Cell Biology]

    Abstract

    LncFALEC Recruits ART5/PARP1 and Promotes Castration-Resistant Prostate Cancer through Enhancing PARP1-Meditated Self PARylation

    Scientists showed focally amplified long non-coding RNA on chromosome 1 (FALEC) was upregulated in post-castration tissues and castration-resistant prostate cancer cells, and increased FALEC expression was associated with poor survival in post-castration prostate cancer patients.
    [Cellular Oncology]

    Abstract

    Long Non-Coding RNA ENST00000503625 Is a Potential Prognostic Biomarker and Metastasis Suppressor Gene in Prostate Cancer

    Researchers identified a novel lncRNA that was down-regulated in prostate cancer and correlated with tumor progression characteristics.
    [Journal Of Cancer Research And Clinical Oncology]

    Abstract

    WDR3 Promotes Stem Cell-Like Properties in Prostate Cancer by Inhibiting USF2-Mediated Transcription of RASSF1A

    WD repeat domain 3 (WDR3) was negatively correlated with USF2, which was degraded by promoting ubiquitination of USF2, and USF2 interacted with promoter region-binding elements of RASSF1A to depress prostate cancer stemness and growth.
    [The Journal Of Gene Medicine]

    Abstract

    Effect and Mechanism of lncRNA-PCMF1/Hsa-miR-137/Twist1 Axis Involved in the EMT Regulation of Prostate Cancer Cells

    Scientists reported for the first time a long non-coding RNA-PCMF1 which promoted the progression of epithelial-mesenchymal transition in prostate cancer cells.
    [Molecular Biotechnology]

    Abstract

    Metabolic Shift towards Oxidative Phosphorylation Reduces Cell Density-Induced Cancer Stem Cell-Like Characteristics in Prostate Cancer In Vitro

    The authors uncovered the relationship between cell density and cancer stem cells (CSCs), and the role of the Warburg effect in regulating CSC-like characteristics.
    [Biology Open]

    Abstract
    Tumors Are 3D. Shouldn't Your In Vitro Model Be? Learn More.
    REVIEWS

    New Insight in Urological Cancer Therapy: From Epithelial-Mesenchymal Transition (EMT) to Application of Nano-Biomaterials

    The role of the EMT mechanism in regulating urological cancer progression is evaluated and for this purpose, a description of urological cancers, pathogenesis, and some basic information about their metastasis potential is provided.
    [Environmental Research]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Curium Confirms No Supply Challenges in North America and Europe for Its Eclipse Phase III Clinical Trial

    Curium confirmed that the company has no foreseeable supply challenges of 177Lu-PSMA-I&T for the company’s ECLIPSE Phase III clinical trial ongoing in the USA, France, Spain, and Italy.
    [Curium]

    Press Release
    FEATURED EVENT

    Genomics of Rare Disease

    April 24 – 26, 2023
    Hinxton, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Studentship – Novel Biomarkers and Treatment Targets

    Newcastle University – Newcastle upon Tyne, England, United Kingdom

    Postdoctoral Fellow – Jak-Stat Signaling in Prostate and Pancreatic Cancer

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Research Assistant Professor – Urology

    University of Miami – Miami, Florida, United States

    Research Technician – Genitourinary Cancers

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Program Coordinator – Prostate Cancer Supportive Care

    Vancouver Prostate Centre – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter